A Comparison of Adolescent Group Therapy and Transitional Family Therapy for Adolescent Alcohol and Drug Abusers
NCT ID: NCT00484367
Last Updated: 2011-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
120 participants
INTERVENTIONAL
1999-07-31
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Family-based and Adolescent Residential Drug Treatment
NCT01737632
Family Based Contingency Management for Adolescent Alcohol Abuse
NCT00595478
Couples Therapy for Alcoholic Patients
NCT01659957
Transitional Treatment of Adolescents in Family Therapy
NCT00680381
A Brief Intervention for Young Adult Substance Users With Interpersonal Trauma
NCT07118826
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The participants were males and females, ages 13-17 at intake, with a DSM-IV diagnosis of either alcohol abuse or alcohol dependence. Following random assignment to condition, basic treatment in both conditions was based on a 12-session model and took approximately 3-4 months, followed by 1-2 aftercare sessions over an additional 1-2 months. The treatment was provided by therapists who were already working within the community (as opposed, for instance, to graduate students). Follow-up assessments were obtained at 3 months post-treatment, 1 year post-treatment, and 2 years post-treatment, thus allowing determination of the extent to which treatment effects "held up" to a degree not attained by most of the previous outcome studies within this domain.
Comparisons: AGT and TFT are being compared on the extent to which their participants used alcohol, as well as other substances, during the three post-treatment periods. Other comparisons include school performance (grade point average), family relations/functioning, and involvement with the legal system.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 AGT
Adolescent group therapy
Adolescent group therapy
2 TFT
Transitional family therapy
Transitional family therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adolescent group therapy
Adolescent group therapy
Transitional family therapy
Transitional family therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants had a current DSM-IV diagnosis of either alcohol abuse or alcohol dependence.
* Participants signed a witnessed informed consent.
* Parent or custodian of each (adolescent) participant signed a witnessed informed consent.
Exclusion Criteria
* Enrollment in a residential substance abuse treatment program within 2 months prior to intake.
13 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
The Morton Center, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
The Morton Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Morris D. Stanton, PhD
Role: PRINCIPAL_INVESTIGATOR
The Morton Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Morton Center
Louisville, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIH Grant R01 AA12178
Identifier Type: -
Identifier Source: secondary_id
NIAAA-STA12178
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.